{"id":226071,"date":"2026-06-04T11:36:00","date_gmt":"2026-06-04T15:36:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/06\/04\/alnylam-inceptive-ink-ai-deal-potentially-worth-2b\/"},"modified":"2026-06-04T11:40:12","modified_gmt":"2026-06-04T15:40:12","slug":"alnylam-inceptive-ink-ai-deal-potentially-worth-2b","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/06\/04\/alnylam-inceptive-ink-ai-deal-potentially-worth-2b\/","title":{"rendered":"Alnylam, Inceptive ink AI deal potentially worth $2B"},"content":{"rendered":"<p><a href=\"https:\/\/www.biopharmadive.com\/news\/alnylam-inceptive-ai-drug-discovery-rna-deal-artificial-intelligence\/822008\/\">Alnylam, Inceptive ink AI deal potentially worth $2B<\/a><\/p>\n<p><a href=\"https:\/\/www.biopharmadive.com\/news\/alnylam-inceptive-ai-drug-discovery-rna-deal-artificial-intelligence\/822008\/\">https:\/\/www.biopharmadive.com\/news\/alnylam-inceptive-ai-drug-discovery-rna-deal-artificial-intelligence\/822008\/<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-06-04 11:36:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.biopharmadive.com\">www.biopharmadive.com<\/a><\/p>\n<ul>\n<li>Alnylam Pharmaceuticals has partnered with biotechnology company Inceptive Nucleics to utilize AI tools to expedite the discovery of new RNA-based therapies.<\/li>\n<li>The initial partnership includes $30 million in cash and equity investments, with additional potential payments reaching up to $2 billion based on preclinical, regulatory, and commercial milestones.<\/li>\n<li>The collaboration aims to support Alnylam\u2019s \u201cambitious pipeline expansion\u201d under its \u201cAlnylam 2030\u201d strategic plan, seeking to prioritize the most promising molecules and enhance experimental productivity.<\/li>\n<li>Inceptive\u2019s AI model is designed to learn biological patterns, potentially identifying optimal targets for Alnylam&#8217;s RNA interference technique aimed at disease-causing proteins.<\/li>\n<li>The use of AI in drug development represents a shift from traditional trial-and-error methods, with proponents arguing that it holds the key to focusing on the most promising therapies.<\/li>\n<li>Despite skepticism regarding the long-term efficacy of AI in drug development, many pharmaceutical companies, including Bristol Myers Squibb, Merck &amp; Co., Novo Nordisk, Takeda, and Eli Lilly, are actively adopting AI-driven strategies to revolutionize their operations.<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alnylam, Inceptive ink AI deal potentially worth $2B https:\/\/www.biopharmadive.com\/news\/alnylam-inceptive-ai-drug-discovery-rna-deal-artificial-intelligence\/822008\/ Publish Date: 2026-06-04 11:36:00 Source Domain:&#8230;<\/p>\n","protected":false},"author":1,"featured_media":226072,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/imgproxy.divecdn.com\/1MCWyHhguqpWVzOesZKtHHOMAeSL7X_TQqt4Q6c5iOI\/g:ce\/rs:fit:770:435\/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9BbG55bGFtX1Bob3RvXzEuSlBH.webp","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[],"class_list":["post-226071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/226071"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=226071"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/226071\/revisions"}],"predecessor-version":[{"id":226074,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/226071\/revisions\/226074"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/226072"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=226071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=226071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=226071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}